A detailed history of O'Neil Global Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, O'Neil Global Advisors, Inc. holds 33,763 shares of CORT stock, worth $2.3 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
33,763
Holding current value
$2.3 Million
% of portfolio
0.5%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$44.66 - $60.85 $1.51 Million - $2.05 Million
33,763 New
33,763 $1.7 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.28B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track O'Neil Global Advisors, Inc. Portfolio

Follow O'Neil Global Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.